SCHEMBL5593578

SCHEMBL5593578

CC(=O)c1ccc(Cn2sccc2=O)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 3/20 0.60
HPGD P15428 3/20 0.60
ALDH1A1 P00352 3/20 0.60
G6PD P11413 2/20 0.60
ALOX15 P16050 2/20 0.60
MAPT P10636 2/20 0.60
PKM P14618 1/20 0.60
HTT P42858 1/20 0.60
TDP1 Q9NUW8 1/20 0.60
KMT2A Q03164 2/20 0.47
TP53 P04637 1/20 0.45
HSP90AA1 P07900 1/20 0.45
CYP3A4 P08684 1/20 0.45
TSHR P16473 1/20 0.45
HIF1A Q16665 1/20 0.45
LMNA P02545 3/20 0.42
HRH3 Q9Y5N1 6/20 0.40
HRH4 Q9H3N8 1/20 0.39
MAOB P27338 2/20 0.39
MAOA P21397 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5593792 0.81 ALDH1A1 (0.71) HSD17B10HPGDALDH1A1G6PDALOX15
SCHEMBL9132689 0.80 ALDH1A1 (0.68) HSD17B10HPGDALDH1A1G6PDALOX15
SCHEMBL2808252 0.78 ALDH1A1 (0.70) HSD17B10HPGDALDH1A1G6PDALOX15
SCHEMBL5593583 0.76 ALDH1A1 (0.68) HSD17B10HPGDALDH1A1G6PDALOX15
SCHEMBL81081 0.75 ALDH1A1 (0.62) HSD17B10HPGDALDH1A1G6PDALOX15
SCHEMBL9321009 0.72 ALDH1A1 (0.62) HSD17B10HPGDALDH1A1G6PDALOX15
SCHEMBL14640378 0.72 KAT2B (0.49) HSD17B10HTTKMT2ALMNAHRH3
SCHEMBL12397259 0.72 ALDH1A1 (0.49) HSD17B10HPGDALDH1A1G6PDALOX15
SCHEMBL1885239 0.69 PTGS1 (0.71) HSD17B10MAPTKMT2ALMNAHRH3
SCHEMBL5917427 0.69 ALDH1A1 (0.67) HSD17B10HPGDALDH1A1G6PDALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007001932-A2 SUBSTITUTED ISOTHIAZOLONES AS INHIBITORS OF CYTOSOLIC PHOSPHOLIPASE A2 JANSSEN PHARMACEUTICA N.V. (BE) 2007-01-04 WO disclosed
WO-2007001932-A2 SUBSTITUTED ISOTHIAZOLONES AS INHIBITORS OF CYTOSOLIC PHOSPHOLIPASE A2 JANSSEN PHARMACEUTICA N.V. (BE) 2007-01-04 WO disclosed
US-20060293374-A1 Substituted isothiazolones JANSSEN PHARMACEUTICA N.V. (BE) 2006-12-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060293374-A1 Substituted isothiazolones LTB4R2, PTGES2, CYSLTR2 HSD17B10 372/4885HPGD 168/4885ALDH1A1 850/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.